HLA DR phenotypic frequencies and genetic risk of Type 1 diabetes in west region of Algeria, Tlemcen

BMC Genetics

Volumn 5, Issue , 2004, Pages

  Aribi, Mourad ^a,b   Moulessehoul, Soraya ^a   Benabadji, Ahmed Bakir ^b   Kendoucitani, Mohammed ^b  

^a UNIVERSITY OF SIDI BEL ABBES   (Algeria)

^b UNIVERSITY OF TLEMCEN   (Algeria)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN;

ADOLESCENT; ADULT; ALGERIA; ARTICLE; CASE CONTROL STUDY; CELL MEDIATED CYTOTOXICITY; CHILD; CLINICAL ARTICLE; CONSANGUINEOUS MARRIAGE; CONSANGUINITY; CONTROLLED STUDY; EXPERIMENTAL DESIGN; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATHOGENESIS; PHENOTYPE; POPULATION RESEARCH; RETROSPECTIVE STUDY; SEROEPIDEMIOLOGY; SEX DIFFERENCE; UNIVERSITY HOSPITAL;

EID: 25444521313     PISSN: 14712156     EISSN: 14712156     Source Type: Journal    
DOI: 10.1186/1471-2156-5-24     Document Type: Article

References (34)

1. Gorus FK, Vandewalle CL, Winnock F, Lebleu F, Keymeulen B, Van der Auwera B, Falorni A, Dorchy H, Féry F, Pipeleers DG, the Belgian Diabetes Registry: Increased prevalence of abnormal immunoglobulin M, G, and A concentrations at clinical onset of insulin-dependent diabetes mellitus: a registry-based study. Pancreas 1998, 1:50-59.
2. Erbaǧci AB, Tarakçioǧlu M, Coşkun Y, Sivasli E, Namiduru ES: Mediators of inflammation in children with type 1 diabetes mellitus: cytokines in type 1 diabetic children. Clin Biochem 2001, 34:645-50.
3. Hill NJ, Van Gunst K, Sarvetnick N: Th1 and Th2 pancreatic inflammation differentially affect homing of islet-reactive CD4 cells in nonobese diabetic mice. J Immunol 2003, 170:1649-58.
4. Kulmala P, Savola K, Petersen JS, Vähäsalo P, Karjalainen J, Löppönen T, Dyrberg T, Åkerblom HK, Knip M, Childhood Diabetes in Finland Study Group: Prediction of Insulin-dependent Diabetes Mellitus in Siblings of Children with Diabetes. A population-based Study. J Clin Invest 1998, 2:327-36.
5. Kida K, Kaino Y, Ito T, Hirai H, Nakamura K: Immunogenetics of insulin-dependent diabetes mellitus. Acta Pædiatr 1999, Suppl 427:3-7.
6. Dorman J, the WHO DiaMon Molecular Epidemiologie Sub-Project Group: Molecular Epidemiology of Insulin-dependent Diabetes Mellitus: WHO Diamon Project. Gac Méd Méx 1997, Suppl 1:151-4.
7. Bourcigaux N, Charbonnel B: Diabète insulino-dépendant: Etiologie, physiopathologie, diagnostic, complications, pronostic, traitement. La Revue du Praticien 1997, 47:1583-92.
8. Scott FW, Norris JM, Kolb H: Milk and type 1 diabetes. Diabetes Care 1996, 19:379-83.
9. Akerblom HK, Knip M, Simell O: From pathomecanisms to prediction, prevention and improved care of insulin-dependent diabetes mellitus in children. Ann Med 1997, 29:383-85.
10. Vandewalle CL, Falorni A, Lernmark Å, Goubert P, Dorchy H, Coucke W, Semakula C, Van der Auwera B, Kaufman L, Schuit FC, Pipeleers DG, Gorus FK, the Belgian Diabetes Registry: Associations of GAD-65 and IA-2-autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. Diabetes Care 1997, 10:1547-52.
11. Jiwa F: Diabetes in the 1990s-an overview. Statistical Bulletin 1997, Jan-Mar:2-8.
12. Nepom GT: Immunogenetics and IDDM. Diabetes Rev 1993, 1:93-03.
13. Bach JF: L'origine immunitaire du diabète. La Recherche 1989, 214:1206-15.
14. Honeyman M, Wasserfall C, Nerup J, Rossini A: Prediction and prevention of IDDM. Diabetologia 1997, 40:B58-B61.
15. Amirzargar A, Mostafavi H, Farjadian Sh, Ghaderi A: Association of HLA-class II alleles and susceptibility to type 1 diabetes in southern Iranian patients. Irn J Med Sci 2000, 25:109-13.
16. Fernandes AP, Louzada-Junior P, Foss MC, Donadi EA: HLA-DRB1, DQB1, and DQA1 allele profile in Brazilian patients with type 1 diabetes mellitus. Ann N Y Acad Sci 2002, 958:305-08.
17. Petrone A, Bugawan TL, Mesturino CA, Nistico L, Galgani A, Giorgi G, Cascino I, Erlich HA, Di Mario U, Buzzetti R: The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region). Tissue Antigens 2001, 58:385-94.
18. Richens ER, Shaltout A, Bahr GM, Abdella N, Jayyab AK, Al-Saffar M, Behbehani K: Insulin binding substances, autoimmunity and type I diabetes in Kuwaiti patients and their kindred. Acta Diabetol Lat 1989, 26:115-22.
19. Berzina L, Ludvigsson J, Sadauskaite-Kuehne V, Nelson N, Shtauvere-Brameus A, Sanjeevi CB: DR3 is associated with type 1 diabetes and blood group ABO incompatibility. Ann N Y Acad Sci 2002, 958:345-48.
20. Honeyman MC, Harrison LC, Drummond B, Colman PC, Tait BD: Analysis of families at risk for IDDM reveals that HLA antigens influence progression to clinical disease. Mol Med 1995, 1:576-82.
21. Deschamps I, Boitard C, Hors J, Busson M, Marcelli-Barge A, Mogenet A, Robert JJ: Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in sibling according to islet cell antibodies and HLA markers. An 8-year prospective study. Diabetologia 1992, 35:951-57.
22. W8 whith type 1 diabetes mellitus in DR4 patients. Diabetes 1989, 38:942-45.
23. Genovese S, Bonfanti R, Bazzigallupi E, Lampasona V, Banazzi E, Bosi E, Chiumello G, Bonifacio E: Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia 1996, 39:1223-26.
24. Onkamo P, Väänänen M, Karvonen M, Tuomilehto J: Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends. Diabetologia 1999, 42:1395-403.
25. Djoulah S, Khalil I, Beressi JP, Benhamamouch S, Bessaoud K, Deschamps I, Degos L, Hors J: The HLA-DR-B1*0405 haplotype is most strongly associated with IDDM in Algerians. Eur J Immunogenet 1992, 19:381-89.
26. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Heer MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rojers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC: Association of the T-cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature 2003, 6939:506-11.
27. Dausset J: HLA Complexe majeur d'histocompatibilité de l'homme Paris: Flammarion Médecine Sciences; 1989.
28. Terasaki PI, McClelland JD: Microdroplet assay of human serum cytotoxins. Nature 1964, 204:998-00.
29. Carpentier A, Farge D: Transplantation d'organes Paris: Flammarion Médecine Sciences; 1992.
30. Vincenzo C, Margherita C, Graziella I, Giuseppina S, Fortunato M, Vincenzo TL: Clinical significance of HLA-DR+, CD19+, CD10+ immature B-cell phenotype and CD34+ cell detection in bone marrow lymphocytes from children affected with immune thrombocytopenic purpura. Haematologica 1997, 82:471-73.
31. Werner Ch, Klouda PT, Corrêa MC, Vassali P, Jeannet M: Isolation of B- and T-lymphocytes by nylon fiber columns. Tissue Antigens 1977, 9:227-29.
32. Dagnelie P: Théorie et méthodes statistiques: les méthodes de l'inférence statistique Gembloux: A.S.B.L; 1975.
33. Ipsen J: The ubiquitous 2 × 2 table, its parameters and their confidence limits. Scand J Soc Med 1984, 12:121-7.
34. Young KD, Lewis RJ: What is confidence? Part 2: Detailed definition and determination of confidence intervals. Ann Emerg Med 1997, 30:311-18.